Text-only version of this email
If you are having trouble reading this email,
h SupplySides Supplement Journal
Article
5 Pioneering the future of human health through biosolutions
Novozymes and Chr. Hansen have officially merged to form Novonesis, marking the largest merger in Danish history. This powerful
collaboration combines over a century of innovation and expertise, positioning Novonesis as a global leader dedicated to tackling
some of humanity's most pressing challenges through biological solutions.
A highlight of this merger is the formation of the Novonesis human health division, which stands out in the biosolutions landscape
with its unique Strain to Solution™ approach. This capability allows Novonesis to partner with customers from the initial stages
of product ideation all the way to shelf-ready products.
This merger will not only enhance Novonesis' capabilities but also expand it's impact on global health and well-being. Read more
inside!
Read more
In order to view this asset, you must first log in to your SupplySide Supplement Journal account.
Don't have an account? Join the community by signing up here!
Paid content:
NOVONEesiS
Show all